Ob/Gyn Journal Club Notes

Slides:



Advertisements
Similar presentations
M2 Medical Epidemiology
Advertisements

1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Understanding real research 3. Assessment of risk.
Introduction to Risk Factors & Measures of Effect Meg McCarron, CDC.
Measures of Disease Association Measuring occurrence of new outcome events can be an aim by itself, but usually we want to look at the relationship between.
1 The Odds Ratio (Relative Odds) In a case-control study, we do not know the incidence in the exposed population or the incidence in the nonexposed population.
TREATMENT 1 Evaluation of interventions How best assess treatments /other interventions? RCT (randomised controlled trial)
Understanding study designs through examples Manish Chaudhary MPH (BPKIHS)
Absolute, Relative and Attributable Risks. Outcomes or differences that we are interested in:  Differences in means or proportions  Odds ratio (OR)
“A Tale of Two Worlds”
Case-Control Studies (retrospective studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego.
Estimation of Various Population Parameters Point Estimation and Confidence Intervals Dr. M. H. Rahbar Professor of Biostatistics Department of Epidemiology.
AETIOLOGY Case control studies (also RCT, cohort and ecological studies)
Hypothesis Testing Field Epidemiology. Hypothesis Hypothesis testing is conducted in etiologic study designs such as the case-control or cohort as well.
Measures of Association
Risk Concepts and Glossary. Cross-sectional study The observation of a defined population at a single point in time or time interval. Exposure and outcome.
CAT 3 Harm, Causation Maribeth Chitkara, MD Rachel Boykan, MD.
Approaches to the measurement of excess risk 1. Ratio of RISKS 2. Difference in RISKS: –(risk in Exposed)-(risk in Non-Exposed) Risk in Exposed Risk in.
SEARO – CSR Training on Outbreak Investigation Cohort and case-control studies Observational studies.
RATES AND RISK Daniel E. Ford, MD, MPH Johns Hopkins School of Medicine Introduction to Clinical Research July 12, 2010.
Measures of Association and Impact Michael O’Reilly, MD, MPH FETP Thailand Introductory Course.
1 EPI 5240: Introduction to Epidemiology Measures used to compare groups October 5, 2009 Dr. N. Birkett, Department of Epidemiology & Community Medicine,
Measures of Disease Frequency, Effect and Impact Lecture by: Dr Amna Rehana Siddiqui Associate Professor Department of Family & Community Medicine September.
Basic concept of clinical study
Measuring Associations Between Exposure and Outcomes Chapter 3, Szklo and Nieto.
Instructor Resource Chapter 3 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
CROSS SECTIONAL STUDIES
Case Control Studies Dr Amna Rehana Siddiqui Department of Family and Community Medicine October 17, 2010.
Dr.Noura Abouammoh Dr. Afnan Younis.  Define and calculate measure of frequency of disease (Prevalence, Incidence, Attack rate)  Be able to decide when.
CASE CONTROL STUDY. Learning Objectives Identify the principles of case control design State the advantages and limitations of case control study Calculate.
Matched Case-Control Study Duanping Liao, MD, Ph.D Phone:
A short introduction to epidemiology Chapter 2: Incidence studies Neil Pearce Centre for Public Health Research Massey University Wellington, New Zealand.
Analytical Studies Case – Control Studies By Dr. Sameh Zaytoun (MBBch, DPH, DM, FRCP(Manch), DTM&H(UK),Dr.PH) University of Alexandria - Egypt Consultant.
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
Journal Club Curriculum-Study designs. Objectives  Distinguish between the main types of research designs  Randomized control trials  Cohort studies.
Chapter 9: Case Control Studies Objectives: -List advantages and disadvantages of case-control studies -Identify how selection and information bias can.
CROSS SECTIONAL STUDIES
EPID 503 – Class 12 Cohort Study Design.
Instructional Objectives:
Present: Disease Past: Exposure
Comparison of three Observational Analytical strategies
Matched Case-Control Study
Epidemiologic Measures of Association
CRITICAL NUMBERS LIVING WITH RISK
Journal Club Notes.
Evidence-Based Journal Club: Intention-to-Treat, Odds and Risk.
Epidemiological Methods
CASE-CONTROL STUDIES Ass.Prof. Dr Faris Al-Lami MB,ChB MSc PhD FFPH
Journal Club Notes.
Lecture 8 – Comparing Proportions
Measures of Association
Class session 13 Case-control studies
Case-Control Studies.
دانشگاه علوم پزشکی بوشهر دانشکده بهداشت
Prospective Cohort Study (Click or press Enter to follow animation)
Logistic Regression we will go through the pdf first to outline some terms refer to earlier ppt on ODDS RATIOS (Stats Club)
Case-Control Studies.
Epidemiology MPH 531 Analytic Epidemiology Case control studies
Epidemiology MPH 531 Analytic Epidemiology Cohort Studies
Measurements of Risk & Association …
Measures of risk and association
Cohort Study.
Measures of Disease Occurrence
Research Techniques Made Simple: Interpreting Measures of Association in Clinical Research Michelle Roberts PhD,1,2 Sepideh Ashrafzadeh,1,2 Maryam Asgari.
CROSS SECTIONAL STUDIES
Risk Ratio A risk ratio, or relative risk, compares the risk of some health-related event such as disease or death in two groups. The two groups are typically.
Measures of Disease Frequency, Effect and Impact
Effect Modifiers.
Cumulative prevalence of venous thromboembolic events in ITP patients who underwent splenectomy compared with those who did not. Cumulative prevalence.
Lessons from Epi Midterm (S05)
Presentation transcript:

Ob/Gyn Journal Club Notes Martha A. Wojtowycz, PhD January 11, 2019

Learning objectives Distinguish between incidence and prevalence Calculate Absolute Risk, Relative Risk, and Odds Ratios Distinguish between Relative Risk and Absolute Risk Explain relative risk and absolute risk of an outcome to your patients

How do we measure disease? Incidence # of new cases of disease # of individuals at risk for developing disease Over a given time frame (usually 1 year) Usually expressed per 1,000 but can express as appropriate (eg per 100,000 for rare diseases) Incidence of disease in a population is the absolute risk Limitations: natural history- need to be able to define onset of disease (new case)- in some diseases, like TB infection, obesity-may be challenging to define onset of disease

How do we measure disease? Prevalence # of cases of disease (old and new) # of individuals at risk for developing disease At a given time (point prevalence v. period prevalence) Usually expressed per 1,000 but can express as appropriate (e.g., per 100,000 for rare diseases)

Incidence and Prevalence: Acute, self-limited disease Incidence (new cases going in) XXXXXXXXXXXXXXXXXXXXXXXXXXXXXX Prevalence Examples: GI illness, Influenza, pancreatic cancer Cases leaving prevalence pool- cure or death

Incidence and Prevalence: Chronic disease Incidence (new cases going in) XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXX XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX Examples: HIV, DM Prevalence Cases leaving prevalence pool - cure or death

Relative Risk (RR) Ratio of the risk of disease (or incidence rate) in the exposed group to the risk of disease (incidence rate) in the nonexposed group. RR= (Risk in exposed)/(Risk in nonexposed) RR= (Incidence in exposed)/(Incidence in nonexposed)

Relative Risk Interpretation RR > 1.0 Risk in exposed group > risk in nonexposed group; positive association; may be causal RR = 1.0 Equal risks; no association RR < 1.0 Risk in exposed group < risk in nonexposed group; negative association; may be protective

Disease Develops Does Not Develop Total Incidence Rates Exposed a b Relative Risk Disease Develops Does Not Develop Total Incidence Rates Exposed a b a + b a/(a+b) Not exposed c d c + d c/(c+d)

Relative Risk Calculation Incidence in exposed = a/(a+b) Incidence in nonexposed = c/(c+d) RR = (a/(a+b)) / (c/(c+d))

Odds Ratio (OR) Another measure of strength of association Used when we do not have information on the incidence in the exposed or nonexposed Case control study Approximation of Relative Risk OR= (Odds that person with disease was exposed)/ (Odds that person without disease was exposed) OR can be <1.0, = 1.0, >1.0

Odds Ratio Disease (+) (-) History of Exposure a b No history of exposure c d

Odds that person with disease was exposed = a / c Odds Ratio Odds that person with disease was exposed = a / c Odds that person without the disease was exposed = b / d OR = (a/c) / (b/d) = ad / bc

Jorgensen ET Al., “incidence of Venous Thromboembolism after different modes of gynecologic surgery”, Obstetrics and Gynecology, vol. 132, no. 5, November 2018.

Absolute Risk of Venous Thromboembolism Absolute risk (or incidence) of venous thromboembolism is 0.2% or 2 per 1,000 gynecologic surgeries 0.7% or 7 per 1,000 hysterectomies 0.2% or 2 per 1,000 myomectomies Venous thromboembolism is a rare event Patients should be provided with the absolute risk information so that they are aware that this is rare

Relative risk of venous thromboembolism Exposure is minimally invasive gynecologic surgery (laparoscopy or vaginal) Unexposed group underwent laparotomy RR for laparoscopy vs laparotomy Incidence for laparoscopy = 0.19% or 1.9 per 1,000 Incidence for laparotomy = 0.85% or 8.5 per 1,000 RR = .0019/.0085 = 0.22 Shows that laparoscopy has a protective effect Compared with laparotomy, laparoscopic surgery is associated a 78% lower risk of venous thromboembolism

Relative risk of venous thromboembolism RR for vaginal vs laparotomy Incidence for vaginal = 0.06% or 0.6 per 1,000 Incidence for laparotomy = 0.85% or 8.5 per 1,000 RR = .0006/.0085 = 0.07 Shows that vaginal surgery has a protective effect Compared with laparotomy, vaginal surgery is associated a 93% lower risk of venous thromboembolism

What to tell your patient Relative risk allows for a comparison of the absolute risks but caution patients not to overestimate the absolute risk For example, suppose we have a rare event where: Absolute risk for all surgeries is 1 per 1,000 surgeries Absolute risk for surgery type A is 3 per 1,000 surgeries Absolute risk for surgery type B is 0.3 per 1,000 surgeries Relative risk = .003/.0003 = 10.0 Compared with surgery type B, patients who undergo surgery type A are 10 times more likely to experience this rare event

Sample size/Study design issues Despite the fact that this study included over 40,000 surgical encounters, the authors were unable to: Run all of the analyses for myomectomies because of the small numbers of myomectomies Simultaneously adjust for potential confounders because there were very few cases with a venous thromboembolism Case control study design often used to study rare events but is more susceptible to bias